Article de revue
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine
In this safety surveillance study of more than 200,000 DTaP–IPV vaccine recipients, there was no evidence of increased risk for any of the pre-specified adverse events monitored. Continued surveillance of DTaP–IPV vaccine safety may be warranted to monitor for rare adverse events, such as Guillain–Barré syndrome.
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
Vaccine
Volume
25
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Diphtérie
- Coqueluche
- Polio
- Tétanos
Mots-clés
- MAPI
- Surveillance des maladies
